Back to all announcements

DJ Ananda Developments Plc Notice of AGM

 
TIDMANA 
 
ANANDA DEVELOPMENTS PLC 
 
                          ("Ananda" or the "Company") 
 
                                 Notice of AGM 
 
Ananda Developments plc announces that the Company has sent notice to 
shareholders convening the Company's annual general meeting, to be held at the 
offices of Shakespeare Martineau LLP, 6th Floor, 60 Gracechurch Street, London 
EC3V 0HR on 31st July 2019 at 11.00 am. 
 
The directors of the Company accept responsibility for the contents of this 
announcement. 
 
                                    --ENDS- 
 
Ananda Developments plc                +44 (0)20 7520 9266 
CEO                                    ir@anandadevelopments.com 
Melissa Sturgess 
 
Investor Relations 
Jeremy Sturgess-Smith 
 
Peterhouse Capital Limited             +44 (0)20 7469 0930 
Corporate Finance 
Fungai Ndoro 
Mark Anwyl 
 
Corporate Broker 
Lucy Williams 
Duncan Vasey 
 
Stanford Capital Partners Limited      +44 (0)20 3815 8880 
Joint Corporate Broker 
John Howes 
Patrick Claridge 
 
Celicourt Communications 
Mark Antelme 
Ollie Mills 
 
Notes to editors 
 
About Ananda Developments PLC 
 
Ananda Developments invests in the developing market for medical or therapeutic 
Cannabis derivatives, or related products, including but not limited to 
nutraceuticals, dietary supplements and cosmetic products which contain 
Cannabis or hemp derived cannabinoids. The Directors believe that this market 
is growing due to an increasing number of states in the USA, as well as other 
countries around the world, changing their laws to allow for products 
containing constituents of Medical Cannabis to be developed, approved and sold. 
 
A copy of the Company's Admission Document is available at 
www.anandadevelopments.com/wp-content/uploads/2019/03/ 
ANANDA-DEVELOPMENTS-Admission-Document-29.06.2018-FINAL-clean.pdf 
 
Ananda's investment strategy is to invest in companies, projects or products 
that are progressing medical or therapeutic Cannabis research and development, 
or seeking to produce or cultivate Cannabis in any jurisdiction in which it is 
legal to do so, or are developing or have already developed, products that 
contain Cannabis derived cannabinoids and require funding to progress work 
plans or commercialise products. 
 
http://www.anandadevelopments.com 
 
 
 
END 
 

(END) Dow Jones Newswires

July 04, 2019 04:09 ET (08:09 GMT)